Strikingly, these indels are also detected in ALL patient samples but not samples from healthy donors, indicating that dPCR can provide a novel diagnostic for early detection of patients with aberrant AID expression that would increase cancer risk. The gene discussed is AICDA; the disease is acute lymphoblastic leukemia.